![]() ![]() | Berkovic, P., GULYBAN, A., Defraene, G., Swenen, L., Dechambre, D., NGUYEN, P. V., Jansen, N., MIEVIS, C., LOVINFOSSE, P., Janvary, L., Lambrecht, M., & De Meerleer, G. (2020). Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases. BMC Cancer, 20 (1), 402. doi:10.1186/s12885-020-06906-1 ![]() |
![]() ![]() | Kahan, Z., Rarosi, F., Gaal, S., Cserhati, A., Boda, K., Darazs, B., Koszo, R., Lakosi, F., GULYBAN, A., COUCKE, P., & Varga, Z. (2018). A simple clinical method for predicting the benefit of prone vs. supine positioning in reducing heart exposure during left breast radiotherapy. Radiotherapy and Oncology. doi:10.1016/j.radonc.2017.12.021 ![]() |
![]() ![]() | Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006 ![]() |
![]() ![]() | Vandaele, R., LALLEMAND, F., MARTINIVE, P., GULYBAN, A., JODOGNE, S., COUCKE, P., Geurts, P., & Marée, R. (2017). Automated multimodal volume registration based on supervised 3D anatomical landmark detection. In SCITEPRESS Digital Library. ![]() |
![]() ![]() | Paelinck, L., GULYBAN, A., Lakosi, F., Vercauteren, T., De Gersem, W., Speleers, B., Monten, C., Mulliez, T., Berkovic, P., van Greveling, A., Decoster, F., Coucke, P., De Neve, W., & Veldeman, L. (2017). Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial. Radiotherapy and Oncology, 122 (1), 30-36. doi:10.1016/j.radonc.2016.12.023 ![]() |
![]() ![]() | Harkati, R., Bare, M., GULYBAN, A., Dechambre, D., Berkovic, P., & Coucke, P. (2017). Hemangiomes vertebraux multiples traites simultanement en condition stereotaxique avec la technologie CyberKnife(R). Revue Médicale de Liège, 72 (7-8), 349-353. ![]() |
![]() ![]() | Janvary, Z. L., JANSEN, N., BAART, V., DEVILLERS, M., DECHAMBRE, D., LENAERTS, E., SEIDEL, L., BARTHELEMY, N., BERKOVIC, P., GULYBAN, A., lakosi, F., zsolt, H., & COUCKE, P. (2017). Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy. Radiology and Oncology, 51 (2), 178-186. doi:10.1515/raon-2017-0015 ![]() |
![]() ![]() | Lakosi, F., GULYBAN, A., BEN MUSTAPHA, S., NGUYEN, V. P., CUCCHIARO, S., SEIDEL, L., JANVARY, L., NICOLAS, S., VAVASSIS, P., & COUCKE, P. (July 2016). The Influence of Treatment Position (Prone vs. Supine) on Clip Displacement, Seroma, Tumor Bed and Partial Breast Target Volumes: Comparative Study. Pathology Oncology Research, 22 (3), 493-500. doi:10.1007/s12253-015-0028-3 ![]() |
![]() ![]() | Lakosi, F., GULYBAN, A., BEN MUSTAPHA, S., NGUYEN, V. P., BERKOVIC, P., NOEL, M., GOURMET, N., & COUCKE, P. (15 May 2016). Feasibility evaluation of prone breast irradiation with the Sagittilt© system including residual-intrafractional error assessment. Cancer Radiotherapie, 3429. doi:10.1016/j.canrad.2016.05.014 ![]() |
![]() ![]() | Vandaele, R., Marée, R., COUCKE, P., GULYBAN, A., LALLEMAND, F., Geurts, P., JODOGNE, S., & MARTINIVE, P. (April 2015). Automated Landmark Detection For Rigid Registration Between The Simulation-CT and the Treatment CBCT [Poster presentation]. 3rd ESTRO FORUM, Barcelone, Spain. |
![]() ![]() | LAKOSI, F., DE CUYPERE, M., NGUYEN, V. P., JANSEN, N., WARLIMONT, B., GULYBAN, A., GENNIGENS, C., SEIDEL, L., DELBECQUE, K., COUCKE, P., HERMESSE, J., & KRIDELKA, F. (2015). Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience. Acta Oncologica, 54 (9), 1558-1566. doi:10.3109/0284186X.2015.1062542 ![]() |
GULYBAN, A., Mackenzie, M., Mathot, M., Barthelemy, N., & Lakosi, F. (2015). Palliative Radiotherapy Delivery Technologies. In A. Fairchild (Ed.), Palliative Radiation Therapy: Utilization of Advanced Technologies. Nova. ![]() |
![]() ![]() | Lakosi, F., GULYBAN, A., Janvary, L., Simoni, S. B.-M., Jansen, N., SEIDEL, L., Kovacs, A., Vavassis, P., & Coucke, P. (2015). Respiratory Motion, Anterior Heart Displacement and Heart Dosimetry: Comparison Between Prone (Pr) and Supine (Su) Whole Breast Irradiation. Pathology Oncology Research. doi:10.1007/s12253-015-9932-9 ![]() |
![]() ![]() | Devillers, M., Lakosi, F., Janvary, L., Ben Mustapha, S., Lenaerts, E., Coucke, P., & GULYBAN, A. (2014). Streamlined clinical CBCT protocols: Reduced dose and variation and maintained image quality. Radiotherapy and Oncology, ESTRO 33, 1738. ![]() |
![]() ![]() | Cucchiaro, S., Dechambre, D., Ernst, C., Martin, N., Sequenzia, F., Ben Mustapha, S., Lakosi, F., Coucke, P., & GULYBAN, A. (2014). Clinical introduction of an all-in class solution for prone breast hypofractionated SIB with multibeam IMRT. Radiotherapy and Oncology, ESTRO 33, 0090. ![]() |
![]() ![]() | GULYBAN, A., Cucchiaro, C., Mathot, M., Ernst, C., Martin, N., Sequenzia, F., Ben Mustapha, S., Coucke, P., & Lakosi, F. (2014). Combined FiF+ Tangent-to-tangents VMAT breast SIB technique: Clinical introduction of an optimal class solution. Radiotherapy and Oncology, ESTRO 33, 0142. ![]() |
![]() ![]() | Lakosi, F., Ben Mustapha, S., GULYBAN, A., Cucchiaro, S., Ernst, C., Martin, N., Sequenzia, F., & Coucke, P. (2014). Hypofractionated whole prone breast RT using Sagittilt system: patient comfort, setup accuracy and acute toxicity. Radiotherapy and Oncology, ESTRO 33, 1204. ![]() |
![]() ![]() | Fairchild, A., Langendijk, J. A., Nuyts, S., Scrase, C., Tomsej, M., Schuring, D., GULYBAN, A., Ghosh, S., Weber, D. C., & Budach, W. (2014). Quality assurance for the EORTC 22071¿26071 study: dummy run prospective analysis. Radiation Oncology, 9 (1), 248. doi:10.1186/s13014-014-0248-9 ![]() |
![]() ![]() | Ben Mustapha, S., Dechambre, D., Mievis, C., Coucke, P., Cucchiaro, C., GULYBAN, A., & Lakosi, F. (2014). Patterns of difficult cases for breast irradiation: where multi-beam IMRT and SIB should be the primary choice. Radiotherapy and Oncology, ESTRO 33, 1197. ![]() |
![]() ![]() | Fenton, P. A., Hurkmans, C., GULYBAN, A., van der Leer, J., Matzinger, O., Poortmans, P., Collette, L., & Bolla, M. (2013). Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: Results of the Dummy Run procedure. Radiotherapy and Oncology. doi:10.1016/j.radonc.2013.04.020 ![]() |
![]() ![]() | Fairchild, A., Collette, L., Hurkmans, C. W., Baumert, B., Weber, D., GULYBAN, A., & Poortmans, P. (2012). 139 DOES QUALITY OF RADIOTHERAPY PREDICT OUTCOMES OF MULTICENTRE CLINICAL TRIALS? THE EORTC RADIATION ONCOLOGY GROUP EXPERIENCE. Radiotherapy and Oncology, 102, 62-S63. doi:10.1016/S0167-8140(12)70111-1 ![]() |
![]() ![]() | Fairchild, A., Aird, E., Fenton, P. A., Gregoire, V., GULYBAN, A., Lacombe, D., Matzinger, O., Poortmans, P., Ruyskart, P., Weber, D. C., & Hurkmans, C. W. (2012). EORTC Radiation Oncology Group quality assurance platform: Establishment of a digital central review facility. Radiotherapy and Oncology, 103 (3), 279-286. doi:10.1016/j.radonc.2012.04.015 ![]() |
![]() ![]() | Fairchild, A., Collette, L., Hurkmans, C. W., Baumert, B., Weber, D. C., GULYBAN, A., & Poortmans, P. (2012). Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials? European Journal of Cancer, 48 (17), 3232-3239. doi:10.1016/j.ejca.2012.06.002 ![]() |
![]() ![]() | Fairchild, A., Weber, D. C., Bar-Deroma, R., GULYBAN, A., Fenton, P. A., Stupp, R., & Baumert, B. G. (2012). Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: The digital individual case review. Radiotherapy and Oncology, 103 (3), 287-292. doi:10.1016/j.radonc.2012.04.002 ![]() |
![]() ![]() | Nalbantov, G., De Ruysscher, D., Vandecasteele, K., GULYBAN, A., De Neve, W., Dekker, A., Hanbeukers, B., Oberije, C., & Lambin, P. (2012). OC-0501 IRRADIATION OF THE LEFT VENTRICLE OF THE HEART IS CORRELATED WITH POST-TREATMENT DYSPNEA IN NSCLC PATIENTS. Radiotherapy and Oncology, 103, 201-S202. doi:10.1016/S0167-8140(12)70840-X ![]() |
![]() ![]() | GULYBAN, A., Oltenau, A. M. L., Vercauteren, T., Speleers, B., De Gersem, W., Van Geel, N., Paelinck, L., Van Eijkeren, M., De Wagter, C., & De Neve, W. (2012). EP-1420 ADAPTIVE CLINICAL COMMISSIONING OF MONACO VMAT: MAXIMIZING EFFICACY WITHOUT SACRIFICING SAFETY. Radiotherapy and Oncology, 103, 541. doi:10.1016/S0167-8140(12)71753-X ![]() |
![]() ![]() | Sebestyén, Z., Kovács, P., GULYBAN, A., Farkas, R., Bellyei, S., Szigeti, A., Gallainé, D. F., & Mangel, L. (2011). Modern három dimenziós konformális craniospinalis besugárzási technika. Magyar Onkologia, 55 (3), 187-192. ![]() |
![]() ![]() | GULYBAN, A., Fenton, P. A., Fairchild, A., Aird, E., Grégoire, V., Lacombe, D., Matzinger, O., Poortmans, P., Baumert, B. G., Pascal, R., Weber, D. C., & Hurkmans, C. W. (2011). 182 oral EORTC RADIOTHERAPY QUALITY ASSURANCE PLATFORM: ESTABLISHMENT OF AN INTEGRATED CENTRAL REVIEW FACILITY. Radiotherapy and Oncology, 99, 71-S72. doi:10.1016/S0167-8140(11)70304-8 ![]() |
![]() ![]() | Sebestyen, Z., Kovacs, P., GULYBAN, A., Farkas, R., Bellyei, S., Liposits, G., Szigeti, A., Esik, O., Derczy, K., & Mangel, L. (2011). Conkiss: conformal kidneys sparing 3D noncoplanar radiotherapy treatment for pancreatic cancer as an alternative to IMRT. Medical Dosimetry, 36 (1), 35-40. doi:10.1016/j.meddos.2009.11.001 ![]() |
![]() ![]() | Weber, D. C., Poortmans, P. M. P., Hurkmans, C. W., Aird, E., GULYBAN, A., & Fairchild, A. (2011). Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting. Radiotherapy and Oncology, 100 (1), 150-156. doi:10.1016/j.radonc.2011.05.073 ![]() |
![]() ![]() | Duchateau, M., Verellen, D., Depuydt, T., Tournel, K., Reynders, T., Gevaert, T., Leysen, K., GULYBAN, A., Poels, K., & de Ridder, M. (2011). 69 speaker 3D DOSIMETRY SYSTEMS-GELS, EPIDS AND OTHERS. Radiotherapy and Oncology, 99, 27. doi:10.1016/S0167-8140(11)70192-X ![]() |
![]() ![]() | Kovács, P., Sebestyén, Z., Farkas, R., Bellyei, S., Szigeti, A., GULYBAN, A., Horváth, Z., Dóczi, T., & Mangel, L. (2011). Konformális sztereotaxiás együléses sugársebészeti kezelés: tervértékelési módszerek és eredmények. Magyar Onkologia, 55 (2), 85-90. ![]() |
![]() ![]() | Fairchild, A., GULYBAN, A., Denis, J. M., Vynckier, S., Hernandez, N., Molineu, A., Followill, D., Fenton, P. A., Weber, D. C., Hurkmans, C. W., & Grégoire, V. (2011). 392 poster INTERNATIONAL IMRT CREDENTIALING BY PHYSICAL PHANTOM IRRADIATION: THE EORTC ROG EXPERIENCE. Radiotherapy and Oncology, 99, 155. doi:10.1016/S0167-8140(11)70514-X ![]() |
![]() ![]() | Matzinger, O., Heimsoth, I., Poortmans, P., Collette, L., Struikmans, H., Bogaert, W. V. D., Fourquet, A., Bartelink, H., Ataman, F., GULYBAN, A., Pierart, M., & Tienhoven, G. V. (2010). Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage i to III breast cancer (EORTC trial 22922/10925). Acta Oncologica, 49 (1), 24-34. doi:10.3109/02841860903352959 ![]() |
![]() ![]() | Musat, E., Roelofs, E., Bar-Deroma, R., Fenton, P., GULYBAN, A., Collette, L., Stupp, R., Weber, D. C., Davis, J. B., Aird, E., & Baumert, B. G. (2010). Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning. Radiotherapy and Oncology, 95 (2), 218-224. doi:10.1016/j.radonc.2010.03.005 ![]() |
![]() ![]() | Matzinger, O., Gerber, E., Bernstein, Z., Maingon, P., Haustermans, K., Bosset, J. F., GULYBAN, A., Poortmans, P., Collette, L., & Kuten, A. (2009). EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiotherapy and Oncology, 92 (2), 164-175. doi:10.1016/j.radonc.2009.03.018 ![]() |
![]() ![]() | Matzinger, O., Poortmans, P., Giraud, J.-Y., Maingon, P., Budiharto, T., van den Bergh, A. C. M., Davis, J. B., Musat, E., Ataman, F., Huyskens, D. P., GULYBAN, A., & Bolla, M. (2009). Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review. Radiotherapy and Oncology, 90 (3), 285-290. doi:10.1016/j.radonc.2008.10.022 ![]() |
![]() ![]() | Matzinger, O., Duclos, F., Bergh, A. V. D., Carrie, C., Villà, S., Kitsios, P., Poortmans, P., Sundar, S., van der Steen-Banasik, E. M., GULYBAN, A., Collette, L., & Bolla, M. (2009). Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. European Journal of Cancer, 45 (16), 2825-2834. doi:10.1016/j.ejca.2009.07.009 ![]() |
![]() ![]() | GULYBAN, A., Hortobágyi, E., Sebestyén, Z., Kovács, P., Liposits, G., Farkas, R., Hideghéty, K., Mangel, L., & Ésik, O. (2008). Improving patient positioning accuracy for breast cancer radiation therapy by using the infra red based ExacTrac system. Nowotwory, 58 (5), 435-437. ![]() |
![]() ![]() | GULYBAN, A., Kovács, P., Sebestyén, Z., Farkas, R., Csere, T., Karácsonyi, G., Dérczy, K., Hideghéty, K., & Ésik, O. (2008). Multisegmented tangential breast fields: A rational way to treat breast cancer. Strahlentherapie und Onkologie, 184 (5), 262-269. doi:10.1007/s00066-008-1770-1 ![]() |
![]() ![]() | GULYBAN, A., Kovacs, P., Farkas, R., Sebestyen, Z., Derczy, K., Hideghety, K., & Esik, O. (2007). Multisegmented radiation therapy as an alternative to 3D conformal radiation therapy, with special reference to breast cancer tangential fields. Nowotwory, 57 (3), 291-293. ![]() |
![]() ![]() | GULYBAN, A., Kovács, P., Bellyei, S., Farkas, R., Strassz, A., Foldvari, D., Derczy, K., Sebestyén, Z., Hideghéty, K., & Esik, O. (2006). Multisegmented tangential breast fields: an effective step towards IMRT without a significantly higher secondary cancer risk. Radiotherapy and Oncology, 81 (suppl 1), 172. ![]() |
![]() ![]() | Al-Farhat, Y., Kovács, P., GULYBAN, A., Farkas, R., Liposits, G., Boronkai, A., Kelemen, D., & Ésik, O. (2006). Radiochemothreapy for stage III pancreatic cancer. Radiotherapy and Oncology, 81 (suppl1), 303. ![]() |
![]() ![]() | Hideghéty, K., Kahan, Z., Thurzo, L., GULYBAN, A., Farkas, R., Bellyei, S., Esik, O., Mitine, C., & Slosarek, K. (2006). Interim Report on clinical testing of a comprehensive solution for patient positioning and immobilization for high tech RT. Radiotherapy and Oncology, 81 (supplement 1), 434. ![]() |
![]() ![]() | Farkas, R., Al-Farhat, Y., GULYBAN, A., Kovács, P., Bellyei, S., Csere, T., Stefanits, K., Derczy, K., Horvath, O. P., Illenyi, L., Sule, N., Szilagyi, K., Bogner, B., & Esik, O. (2006). Neoadjuvant Radiochemotherapy of Locally/Regionally Advanced Rectal Cancer is a standard treatment option. Radiotherapy and Oncology, 81 (suppl1), 237. ![]() |
![]() ![]() | Nemeskéri, C., Póti, Z., Mayer, A., Trón, L., GULYBAN, A., Sáfrány, G., & Ésik, O. (2006). Induced acute erythema and late pigmentation may not be correlated: In regards to Perera et al. (Int J Radiat Oncol Biol Phys 2005;62:1283-1290) [letter to the editor]. International Journal of Radiation, Oncology, Biology, Physics, 65 (1), 309-310. doi:10.1016/j.ijrobp.2006.01.011 ![]() |
![]() ![]() | GULYBAN, A., Bellyei, S., Farkas, R., Strassz, A., Kovács, P., Gallainé, D. F., Dérczy, K., Hideghéty, K., & Ésik, O. (2005). Az emlőbesugárzásnál alkalmazott tangenciális mezők multiszegmentálásával javiitható a céltérfogat dózis-homogenitása. Magyar Onkologia, 45 (265), 2005. ![]() |